Atlas Trials

Intranasal Oxytocin for the Treatment of Children and Adolescents With ASD (OXY)

Clinical trial NCT01256060 · COMPLETED

Trial details

NCT number
NCT01256060
Sponsor
Evdokia Anagnostou
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2010-11-01
Primary completion
2013-03-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.